Intraoperative Ultrasonographically Guided Excisional Biopsy or Vacuum-Assisted Core Needle Biopsy for Nonpalpable Breast Lesions

Chen, Shin‐Cheh; Yang, Horng Ren; Hwang, Tsann‐Long; Chen, Miin‐Fu; Cheung, Yun‐Chung; Hsueh, Swei

doi:10.1097/01.sla.0000094439.93918.31

Cited by 71 publications

(24 citation statements)

References 30 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This procedure is gradually taking over the so far commonly used fine needle aspiration biopsy whose main disadvantage is a high rate of nondiagnostic results (4-35.4%) and false negative results (2.6-20%) [6, 16–18]. Vacuum-assisted core biopsy provides multiple quality samples from a single insertion compared to a traditional core biopsy [2, 7].…”

Section: Discussionmentioning

confidence: 99%

Ultrasound-guided vacuum-assisted core biopsy in the diagnosis and treatment of focal lesions of the breast - own experience.

Kibil¹,

Hodorowicz-Zaniewska²,

Szczepanik³

et al. 2012

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

IntroductionVacuum-assisted core biopsy (VACB) guided by ultrasound is a minimally invasive method used in diagnosis and treatment of breast focal lesions. Vacuum-assisted core biopsy is an interesting minimally invasive alternative to open surgical biopsy.AimTo assess the value of ultrasound-guided vacuum-assisted core biopsy in the diagnosis and treatment of breast focal lesions.Material and methodsIn the period 2009-2010, 397 ultrasound-guided vacuum-assisted core biopsies were performed. Mean age of the patients was 41.7 years (18-92 years), and size of the lesions ranged from 3 mm to 65 mm, mean size being 12 mm. All women with diagnosed atypical ductal hyperplasia or cancer were qualified for surgery. The patients with histopathologically benign lesions were under follow-up.ResultsSamples sufficient for histopathological examination were obtained from 394 cases (99.2%). Of all 397 lesions, 293 (73.7%) were diagnosed as benign, there were 6 (1.6%) cases of atypical ductal hyperplasia and 98 (24.7%) malignant lesions. Three hundred and sixty-nine lesions were below 15 mm in diameter, of which 339 (91.9%) were totally removed during the VACB.ConclusionsThe results obtained confirm high efficiency of ultrasound-guided VACB in the differential diagnosis of breast focal lesions, including impalpable ones. It is a safe method with a low complication rate. In the case of benign lesions with a diameter not exceeding 15 mm, it allows one to excise the whole lesion and is a very good alternative to an open surgical biopsy. Vacuum-assisted core biopsy should be a standard and the method of choice in diagnosing breast lesions.

show abstract

Section: Discussionmentioning

confidence: 99%

Ultrasound-guided vacuum-assisted core biopsy in the diagnosis and treatment of focal lesions of the breast - own experience.

Kibil¹,

Hodorowicz-Zaniewska²,

Szczepanik³

et al. 2012

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

show abstract

“…VAB has a high diagnostic accuracy [6,7,[10][11][12][13]. The results of VAB under ultrasound guidance for mass lesions are shown in Table 1.…”

Section: Vacuum-assisted Biopsy (Vab)mentioning

confidence: 98%

“…In a retrospective study by Chen [12], the results of VAB and surgical excision for mass lesions were compared. VAB was performed faster than surgical excision with the same morbidity.…”

Section: Vacuum-assisted Biopsy (Vab)mentioning

confidence: 99%

Minimally invasive technology in the management of breast disease

et al. 2008

View full text Add to dashboard Cite

Minimally invasive surgery is gaining popularity around the world because it achieves the same or even superior results when compared to standard surgery but with less morbidity. Minimally invasive breast surgery is a broad concept encompassing new developments in the field of breast surgery that work on this minimally invasive principle. In this regard, breast-conserving surgery and sentinel lymph node biopsy are good illustrations of this concept. There are three major areas of progress in the minimally invasive management of breast disease. First, percutaneous excisional devices are now available that can replace the surgical excision of breast mass lesions. Second, various ablative treatments are capable of destroying breast cancers in situ instead of surgical excision. Third, mammary ductoscopy provides a new approach to the investigation of mammary duct pathology. Clinical experience and potential applications of these new technologies are reviewed.

show abstract

“…There is a common trend in the literature toward routine surgical excision of ADH detected by stereotactic procedures to ensure adequate staging [21][22][23][25][26][27][28][29][30]; however, some authors still disagree because of the many cases of unnecessary removal of these lesions [24,31,32]. Likewise, the standard procedure after diagnosis of lobular neoplasia (ALH/LCIS) by the Mammotome is still controversial.…”

Section: Discussionmentioning

confidence: 99%

Mammotome: Less Invasive than ABBI with Similar Accuracy for Early Breast Cancer Detection

et al. 2005

View full text Add to dashboard Cite

Abstract. We performed a prospective analysis of two consecutive biopsy cohorts investigated by the same team to compare the Mammotome system with the ABBI procedure. From April 1997 to August 2003 a series of 413 nonpalpable mammographic lesions in 387 women (median age 56 years, range 30-84 years) were stereotactically biopsied in the University Hospital of Basel, Switzerland. Until October 1999 the ABBI system was applied exclusively, it was subsequently superseded by the Mammotome device in our clinic. Main outcome measures were accuracy, technical demand, and morbidity. Sensitivity (97.3%/96.8%), negative predictive value (99.2%/98.7%), and diagnostic accuracy (99.4%/99.1%) regarding the detection of malignancy were excellent for both techniques (ABBI/ Mammotome). The Mammotome procedure was faster and less invasive, thus causing significantly less morbidity. The larger specimen obtained by the ABBI procedure resulted in more detailed histology. In conclusion, recommend the Mammotome system as the method of choice for detecting nonpalpable early breast cancer.

show abstract

Intraoperative Ultrasonographically Guided Excisional Biopsy or Vacuum-Assisted Core Needle Biopsy for Nonpalpable Breast Lesions

Abstract: For treatment of nonpalpable breast lesions, both IUGE and DVAB eliminate false-negative results, underestimates, and the requirement for reexcisional biopsies. In comparison to IUGE, DVAB is more convenient and time efficient for excisional biopsy of nonpalpable breast lesions.

Cited by 71 publications

References 30 publications

Ultrasound-guided vacuum-assisted core biopsy in the diagnosis and treatment of focal lesions of the breast - own experience.

Ultrasound-guided vacuum-assisted core biopsy in the diagnosis and treatment of focal lesions of the breast - own experience.

Minimally invasive technology in the management of breast disease

Mammotome: Less Invasive than ABBI with Similar Accuracy for Early Breast Cancer Detection

Contact Info

Product

Resources

About